| Vanta Bioscience Ltd | Industry : (FMCG) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 1.29 | 1.06 | 0.79 | 0.66 | 0.60 |
| Long Term Debt-Equity Ratio | 0.99 | 0.83 | 0.55 | 0.49 | 0.56 |
| Current Ratio | 0.89 | 1.01 | 1.10 | 1.78 | 3.52 |
| Fixed Assets | 0.19 | 0.12 | 0.25 | 0.36 | 0.67 |
| Inventory | 1.17 | 0.72 | 1.10 | 0.84 | 1.21 |
| Debtors | 4.02 | 3.92 | 6.93 | 6.01 | 9.66 |
| Interest Cover Ratio | 1.00 | -0.35 | 1.07 | 1.29 | 1.66 |
| PBIDTM (%) | 42.76 | 2.90 | 38.18 | 39.04 | 31.40 |
| PBITM (%) | 28.27 | -21.28 | 24.06 | 26.59 | 22.96 |
| PBDTM (%) | 14.49 | -57.25 | 15.61 | 18.53 | 17.58 |
| CPM (%) | 14.60 | -57.83 | 14.97 | 17.13 | 15.38 |
| APATM (%) | 0.12 | -82.01 | 0.86 | 4.68 | 6.95 |
| ROCE (%) | 5.24 | 0.00 | 5.24 | 6.75 | 8.87 |
| RONW (%) | 0.05 | 0.00 | 0.33 | 1.99 | 4.29 |